Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabete... von BOLLI, Geremia B, HAHN, Annke D, SCHMIDT, Ronald, EISENBLAETTER, Tanja, DAHMEN, Raphael, HEISE, Tim, BECKER, Reinhard H. A

Volltext

Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 Diabetes von Danne, Thomas, Becker, Reinhard H. A, Heise, Tim, Bittner, Claudia, Frick, Annke D, Rave, Klaus

Volltext

In response to: Heise T, Nørskov M, Nosek L, Kaplan K, Famulla S and Haahr H. L. (2017) Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response co... von Becker, Reinhard H.A.

Volltext

Similar pharmacokinetics and pharmacodynamics of rapid‐acting insulin lispro products SAR342434 and US‐ and EU‐approved Humalog in subjects with type 1 diabetes von Kapitza, Christoph, Nowotny, Irene, Lehmann, Anne, Bergmann, Karin, Rotthaeuser, Baerbel, Nosek, Leszek, Becker, Reinhard H. A.

Volltext

Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia von Lorenz, Martin, Pfeiffer, Claudia, Steinsträßer, Axel, Becker, Reinhard H.A., Rütten, Hartmut, Ruus, Peter, Horowitz, Michael

Volltext

Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin von Rave, Klaus, Bott, Susanne, Heinemann, Lutz, Sha, Sue, Becker, Reinhard H.A, Willavize, Susan A, Heise, Tim

Volltext

Advantage of Premeal-Injected Insulin Glulisine Compared With Regular Human Insulin in Subjects With Type 1 Diabetes von Rave, Klaus, Klein, Oliver, Frick, Annke D, Becker, Reinhard H.A

Volltext

Late Treatment With Ramipril Increases Survival in Old Spontaneously Hypertensive Rats von Linz, Wolfgang, Wohlfart, Paulus, Schoelkens, Bernward A, Becker, Reinhard H.A, Malinski, Tadeusz, Wiemer, Gabriele

Volltext

The Effect of Smoking Cessation and Subsequent Resumption on Absorption of Inhaled Insulin von BECKER, Reinhard H. A, SHA, Sue, FRICK, Annke D, FOUNTAINE, Robert J

Volltext

New insulin glargine 300 Units · mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units · mL-1 von Becker, Reinhard H A, Dahmen, Raphael, Bergmann, Karin, Lehmann, Anne, Jax, Thomas, Heise, Tim

Volltext

Insulin glargine metabolite 21 A -Gly-human insulin (M1) is the principal component circulating in the plasma of young children with type 1 diabetes: results from the PRESCHOOL stu... von Danne, Thomas, Becker, Reinhard HA, Ping, Lin, Philotheou, Areti

Volltext

Dose-Response Relationship off Insulin Glulisine in Subjects With Type 1 Diabetes von Becker, Reinhard H A, Frick, Annke D, Nosek, Leszek, Heinemann, Lutz, Rave, Klaus

Volltext

Variability in Concentration and Glucodynamic Profiles of Insulin Glargine in Healthy Volunteers von Becker, Reinhard H A, Frick, Annke D, Saoud, Jay B, Nosek, Leszek

Volltext

PUBLISHED ONLY: INSULIN ACTION-METABOLISM von Becker, Reinhard H A, Burger, Francois, Scholtz, Herman, Frick, Annke D

Volltext

Pharmacological Interference with the Cardiac Renin-Angiotensin System von Becker, Reinhard H. A, Linz, Wolfgang, Schölkens, Bernward A

Volltext

HMR 1098: An Inhibitor of Cardiac ATP‐Sensitive Potassium Channels von Gögelein, Heinz, Englert, Heinrich C., Kotzan, Astrid, Hack, Rüdiger, Lehr, Karl‐Heinz, Seiz, Werner, Becker, Reinhard H. A., Sultan, Eric, Schölkens, Bernward A., Busch, Andreas E.

Volltext

Ramipril von Becker, Reinhard H. A., Schölkens, Bernward A.

Volltext

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma von Flaherty, Keith T, Robert, Caroline, Hersey, Peter, Nathan, Paul, Garbe, Claus, Milhem, Mohammed, Demidov, Lev V, Hassel, Jessica C, Rutkowski, Piotr, Mohr, Peter, Dummer, Reinhard, Trefzer, Uwe, Larkin, James M.G, Utikal, Jochen, Dreno, Brigitte, Nyakas, Marta, Middleton, Mark R, Becker, Jürgen C, Casey, Michelle, Sherman, Laurie J, Wu, Frank S, Ouellet, Daniele, Martin, Anne-Marie, Patel, Kiran, Schadendorf, Dirk

Volltext

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors von Ortiz-Cuaran, Sandra, Scheffler, Matthias, Plenker, Dennis, Dahmen, Llona, Scheel, Andreas H, Fernandez-Cuesta, Lynnette, Meder, Lydia, Lovly, Christine M, Persigehl, Thorsten, Merkelbach-Bruse, Sabine, Bos, Marc, Michels, Sebastian, Fischer, Rieke, Albus, Kerstin, König, Katharina, Schildhaus, Hans-Ulrich, Fassunke, Jana, Ihle, Michaela A, Pasternack, Helen, Heydt, Carina, Becker, Christian, Altmüller, Janine, Ji, Hongbin, Müller, Christian, Florin, Alexandra, Heuckmann, Johannes M, Nuernberg, Peter, Ansén, Sascha, Heukamp, Lukas C, Berg, Johannes, Pao, William, Peifer, Martin, Buettner, Reinhard, Wolf, Jürgen, Thomas, Roman K, Sos, Martin L

Volltext

Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial von Duvic, Madeleine, Dummer, Reinhard, Becker, Jürgen C, Poulalhon, Nicolas, Ortiz Romero, Pablo, Grazia Bernengo, Maria, Lebbé, Celeste, Assaf, Chalid, Squier, Margaret, Williams, Denise, Marshood, Miriam, Tai, Feng, Prince, H. Miles

Volltext